FAQ
Frequently asked questions
Find answers to commonly asked questions about our technology, platform, and partnership opportunities.
RNA nanotechnology uses programmable RNA molecules as building blocks to construct precisely engineered nanoscale structures for therapeutic delivery and other biomedical applications.
Exosomes are natural extracellular vesicles with intrinsic biocompatibility and cellular targeting capabilities, allowing therapeutic payloads to evade immune detection and reach diseased tissues efficiently.
Our initial focus is oncology, with broader applications across complex diseases that benefit from precise, targeted molecular delivery.
Timelines depend on the specific program and regulatory pathway; we work with partners to design accelerated translational plans tailored to each therapeutic target.
We collaborate with pharmaceutical and biotech partners through co-development, licensing, and custom research programs. Reach out via our contact page to discuss.
Yes. Our team provides technical consulting on RNA nanostructure design, exosome engineering, and translational strategy.